Benzatropine mesilate ( INN ), benztropine mesylate , or benztropine ( USAN ) marketed as Cogentin , is an anticholinergic drug principally used for the treatment of:

Benzatropine is a centrally acting anticholinergic agent with antihistaminic properties resulting from the combination of the tropine portion of the atropine molecule and the benzohydryl portion of diphenhydramine . more

Benzatropine mesilate ( INN ), benztropine mesylate , or benztropine ( USAN ) marketed as Cogentin , is an anticholinergic drug principally used for the treatment of:

Benzatropine is a centrally acting anticholinergic agent with antihistaminic properties resulting from the combination of the tropine portion of the atropine molecule and the benzohydryl portion of diphenhydramine . Animal studies have indicated that anticholinergic activity of benzatropine is approximately one-half that of atropine, while antihistaminic activity approaches that of pyrilamine . Its anticholinergic effects have been established as therapeutically significant in the management of parkinsonism. Benzatropine antagonises the effect of acetylcholine , decreasing the imbalance between the neurotransmitters acetylcholine and dopamine , which may improve the symptoms of early Parkinson's disease. [ 1 ] less